secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001493152-21-027125
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GBS appoints Chairman Steven Boyages as Interim CEO; Harry Simeonidis moves to President APAC
--------------------------------------------------------------------------------

- Chairman Steven Boyages, MD PhD, appointed Interim CEO effective Oct 29, 2021; no additional compensation.
- Harry Simeonidis resigned as CEO, President, and Board member; stays as President Asia Pacific, Sales & Marketing.
- Board initiates search for permanent CEO via leading executive search firm.
- No disagreements between Company and Mr. Simeonidis related to operations, policies, or practices.
- Boyages has extensive healthcare executive experience, including 9 years as CEO of Sydney West Area Health Service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315221027125/0001493152-21-027125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315221027125/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-027125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer